The CD28-CD80/CD86-mediated T-cell costimulatory pathway has been variably implicated in infectious immunity. In this study, we investigated the role of this costimulatory pathway in resistance to
Trypanosoma cruzi infection by using CD28-deficient mice and
blocking antibodies against CD80 and CD86. CD28-deficient mice exhibited markedly exacerbated T. cruzi
infection, as evidenced by unrelenting
parasitemia and 100% mortality after
infection with doses that are nonlethal in wild-type mice. The blockade of both CD80 and CD86 by administering specific
monoclonal antibodies also exacerbated T. cruzi
infection in wild-type mice. Splenocytes from T. cruzi-infected, CD28-deficient mice exhibited greatly impaired
gamma interferon production in response to T. cruzi
antigen stimulation in vitro compared to those from infected wild-type mice. The induction of T. cruzi
antigen-specific CD8(+) T cells was also impaired in T. cruzi-infected, CD28-deficient mice. In addition to these defects in natural protection against T. cruzi
infection, CD28-deficient mice were also defective in the induction of CD8(+)-T-cell-mediated protective immunity against T. cruzi
infection by
DNA vaccination. These results demonstrate, for the first time, a critical contribution of the CD28-CD80/CD86 costimulatory pathway not only to natural protection against primary T. cruzi
infection but also to
DNA vaccine-induced protective immunity to
Chagas' disease.